Ribociclib is an oral medication used in the treatment of certain types of breast cancer. It belongs to a class of drugs known as CDK4/6 inhibitors, which work by interfering with the proteins known as cyclin-dependent kinases (CDK) 4 and 6. These proteins are essential for cancer cell proliferation, and by inhibiting them, ribociclib helps to slow down the growth of cancer cells.
